Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

Primary prevention of type 1 diabetes (T1D) requires intervention in genetically at‐risk infants. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has established a screening program, GPPAD‐02, that identifies infants with a genetic high risk of T1D, enrolls these into primary p...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Christiane, Haupt, Florian, Heigermoser, Martin, Zapardiel‐Gonzalo, Jose, Ohli, Jasmin, Faure, Theresa, Kalideri, Evdokia, Hommel, Angela, Delivani, Petrina, Berner, Reinhard, Kordonouri, Olga, Roloff, Frank, von dem Berge, Thekla, Lange, Karin, Oltarzewski, Mariusz, Glab, Ryszard, Szypowska, Agnieszka, Snape, Matthew D., Vatish, Manu, Todd, John A., Larsson, Helena E., Ramelius, Anita, Kördel, Jeanette Å., Casteels, Kristina, Paulus, Jasmin, Ziegler, Anette G., Bonifacio, Ezio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2019
Materias:
Type 1 Diabetes: Pathophysiology and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851563/
https://www.ncbi.nlm.nih.gov/pubmed/31192505
http://dx.doi.org/10.1111/pedi.12870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851563/
https://www.ncbi.nlm.nih.gov/pubmed/31192505
http://dx.doi.org/10.1111/pedi.12870

Ejemplares similares